๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Elm Park
Clinical trial register · Ireland

Clinical Trials in Elm Park, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 614 matching records held by the registry are in this view. Synced 25 Sep 2026, 03:15 UTC
614
Studies in scope
all four open statuses
320
Recruiting now
open to new participants
179
Lead sponsors
across recruiting studies
37
Irish site locations
across all listed studies
Phase mix of the 320 recruiting studies
Phase 3 96 Not applicable 79 Observational 76 Phase 2 29 Phase 1/2 20 Other 20
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Target enrolment
to

Trials with a site in Elm Park

9 of 614 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Recruiting
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
NCT06764693 Psoriatic Arthritis
AbbVie
Observational
1,200
Dublin, Elm Park, Tralee, Cork
2025-01-31
Active, closed
Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis
NCT04569942 Shock, Septic
Australian and New Zealand Intensive Care Research Centre
Phase 3
1,000
Elm Park
2021-10-26
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163 Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 2
393
Elm Park
2019-03-15
Active, closed
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer
NCT03539536 Non-small Cell Lung Cancer
AbbVie
Phase 2
270
Wilton, Dublin, Elm Park
2018-10-10
Active, closed
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
NCT03105102 Crohn's Disease
AbbVie
Phase 3
1,336
Beaumont, Elm Park, Galway
2018-04-09
Active, closed
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
NCT03006068 Ulcerative Colitis (UC)
AbbVie
Phase 3
950
Dublin, Elm Park, Cork, Galway
2017-01-31
Active, closed
A Long-Term Registry of Humiraยฎ (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
NCT01848561 Ulcerative Colitis (UC)
AbbVie
Observational
8,250
Abbotstown, Dublin, Elm Park, Galway
2013-04-29
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-ireland/city/elm-park

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 614 studies in total at the last sync on 25 Sep 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies with a site in Elm Park.

How many clinical trials are recruiting in Elm Park?

1 of the 9 studies on this page are recruiting new participants as of the 25 Sep 2026, 03:15 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Elm Park), 9 studies
PhaseStudiesRecruitingShare
Observational3133.3%
Phase 23033.3%
Phase 33033.3%

Most active sponsors

Lead sponsors with the most studies (Elm Park)
Lead sponsorStudiesRecruiting
AbbVie71
Astellas Pharma Global Development, Inc.10
Australian and New Zealand Intensive Care Research Centre10
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.